Why CAMP4?
Leadership
Investors
About Our Name
RAP Platform
Reg Actuators
Programmable Therapeutics
Publications & Presentations
Pipeline
Newsroom
Join the Adventure
Recent News
December 3, 2021
CAMP4 Presents In Vivo Data Supporting Novel Therapeutic Strategy for Dravet Syndrome at American Epilepsy Society Annual Meeting
Read More
Contact Us
Privacy Policy
Menu
Newsroom
All
·
In the News
·
Press Releases
December 3, 2021
Press Releases
CAMP4 Presents In Vivo Data Supporting Novel Therapeutic Strategy for Dravet Syndrome at American Epilepsy Society Annual Meeting
October 7, 2021
In the News
Nature Biotechnology
Drug hunters uncloak the non-coding ‘hidden’ genome
September 27, 2021
Press Releases
CAMP4 Presents First Preclinical Data Demonstrating the Therapeutic Potential of its RNA Actuating Platform at the 17th Annual Meeting of the Oligonucleotide Therapeutics Society
July 13, 2021
Press Releases
CAMP4 Therapeutics Expands Leadership and Board of Directors
July 6, 2021
In the News
Boston Business Journal
What’s in a name? Biotech companies look to stand out from the crowd
June 15, 2021
Press Releases
CAMP4 Raises $45 Million to Usher in a New Era of Programmable Therapeutics to Upregulate Genes
October 29, 2019
Press Releases
CAMP4 Therapeutics Expands Board of Directors with Appointment of Steven Holtzman as Chair and Dr. Paula Ragan as Director
October 25, 2019
Press Releases
Richard Young, Ph.D., Founder of CAMP4 Therapeutics, Elected to National Academy of Medicine
1
2
»
Media Contact:
Lindy Devereux
PR@camp4tx.com
Top
